Medtronic

The Fridley-based company makes cardiovascular, cardiac rhythm, neurological, spinal, diabetes and surgical medical device technologies and therapies.

63.84 USD  +1.85 (+2.98%)
Delayed Price  /  Updated: 5:55 PM CDT, Oct 20, 2014  /  Add to My Watchlist      
52 Week High 67.11
52 Week Low 53.33
Volume 12465512
Bid (Size) 200
Ask (Size) 1300
Today's Range 64.07 - 62.18
Shares Outstanding 979516413
Dividend Yield 1.17

key info

Follow Medtronic

Connect with facebook Connect with Linkedin

Related Companies

StarTribune 100

A measure of the largest publicly held companies with headquarters in Minnesota ranked by revenue.

star tribune coverage

Class-action lawsuit over Infuse could put Medtronic-Covidien deal at risk

ARTICLE Updated: Oct 12 2014 - 6:32 AM

A federal judge in Minneapolis has pushed forward a lawsuit involving Medtronic Inc.’s problematic Infuse bone growth product that could complicate the company’s controversial $43 billion...

Medtronic will run Covidien as separate division

ARTICLE Updated: Oct 11 2014 - 7:56 AM

Health care supply company Covidien PLC will remain mostly intact as a separate division of Medtronic Inc. after the proposed $43 billion deal to merge the two companies under a new Irish parent.With...

Schafer: Breaking down Medtronic's tax move

ARTICLE Updated: Oct 9 2014 - 8:06 PM

One of the ironies of this season of tax inversions is that the big Minnesota company that seems hellbent on completing one already pays less than half the 35 percent statutory federal tax rate.That...

Medtronic says Covidien deal will go forward, but changes financing

ARTICLE Updated: Oct 4 2014 - 6:16 AM

Medtronic is pushing ahead with a controversial “tax inversion” deal that could save billions in taxes, despite recent legal changes that aimed to make such maneuvers less attractive.The...

FDA issues new rules on medical device cybersecurity

ARTICLE Updated: Oct 1 2014 - 9:56 PM

Another step has been added to the development process for medical devices: preventing cyberattacks.The U.S. Food and Drug Administration on Wednesday finalized guidelines strongly urging...

See all content

executive compensation

Omar Ishrak

Chm., CEO

Current year rank 13
Current year compensation $8,331,159
Percent change of the CEO 33.0

See more state CEO pay packages

executive team

  • Omar Ishrak, Chairman and CEO
  • Gary Ellis, Senior Vice President and CFO
  • Cameron Findlay, Senior Vice President and General Counsel
  • Michael Coyle, Executive Vice President and Group President, Cardiac and Vascular

twitter feed

minnesota topics minnesota topics

Minnesota Topics are a comprehensive collection of Star Tribune content on select people, places and companies.

ADVERTISEMENT

ADVERTISEMENT

 
Close